Elevance Health, Inc.
ELV Healthcare Healthcare Plans
Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.
Follow ELV
Elevance Health, Inc. (ELV) EV/EBITDA
As of 16 October 2026, Elevance Health, Inc. (ELV) trades at a EV/EBITDA of 9.8×. Over the past ten years it has ranged from 3.8× (November 2016) to 11.6× (July 2021); the current reading is higher than 78% of that period. That is below the Healthcare Plans industry median of 11.5× and above the Healthcare sector median of 9.2×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 7.7× | (1.25%) |
| FY2024 | 7.8× | (19.47%) |
| FY2023 | 9.7× | (11.01%) |
| FY2022 | 10.9× | 7.04% |
| FY2021 | 10.2× | 19.43% |
| FY2020 | 8.5× | (5.70%) |
| FY2019 | 9.0× | (0.49%) |
| FY2018 | 9.1× | 1.04% |
| FY2017 | 9.0× | 90.50% |
| FY2016 | 4.7× | (5.58%) |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Jun 2026 | 8.8× | 37.85% |
| Mar 2026 | 6.4× | (17.13%) |
| Dec 2025 | 7.7× | 13.55% |
| Sep 2025 | 6.8× | (19.04%) |
| 42 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| CNC Centene Corporation compare | n/m |
| CLOV Clover Health Investments, Corp. compare | n/m |
| CI Cigna Group compare | 8.3× |
| CVS CVS Health Corporation compare | 8.9× |
| OSCR Oscar Health, Inc. compare | 9.4× |
| ELV Elevance Health, Inc. | 9.8× |
| HUM Humana Inc. compare | 11.5× |
| MOH Molina Healthcare, Inc compare | 15.3× |
| UNH UnitedHealth Group Incorporated compare | 15.5× |
| Healthcare Plans industry median | 11.5× |
| Healthcare sector median | 9.2× |
| Market median | 11.0× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on ELV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement